122 related articles for article (PubMed ID: 36929051)
1. BORIS variant SF2(C2/A4) promotes the malignant development of liver cancer by activating epithelial-mesenchymal transition and hepatic stellate cells.
Wei L; Liu Z; Qin L; Xian L; Chen K; Zhou S; Hu L; Xiong Y; Li B; Qin Y
Mol Carcinog; 2023 Jun; 62(6):731-742. PubMed ID: 36929051
[TBL] [Abstract][Full Text] [Related]
2. Hepatic stellate cells promote upregulation of epithelial cell adhesion molecule and epithelial-mesenchymal transition in hepatic cancer cells.
Nagahara T; Shiraha H; Sawahara H; Uchida D; Takeuchi Y; Iwamuro M; Kataoka J; Horiguchi S; Kuwaki T; Onishi H; Nakamura S; Takaki A; Nouso K; Yamamoto K
Oncol Rep; 2015 Sep; 34(3):1169-77. PubMed ID: 26165819
[TBL] [Abstract][Full Text] [Related]
3. HSCs-derived COMP drives hepatocellular carcinoma progression by activating MEK/ERK and PI3K/AKT signaling pathways.
Li Q; Wang C; Wang Y; Sun L; Liu Z; Wang L; Song T; Yao Y; Liu Q; Tu K
J Exp Clin Cancer Res; 2018 Sep; 37(1):231. PubMed ID: 30231922
[TBL] [Abstract][Full Text] [Related]
4. Hepatic stellate cells secreted hepatocyte growth factor contributes to the chemoresistance of hepatocellular carcinoma.
Yu G; Jing Y; Kou X; Ye F; Gao L; Fan Q; Yang Y; Zhao Q; Li R; Wu M; Wei L
PLoS One; 2013; 8(9):e73312. PubMed ID: 24023859
[TBL] [Abstract][Full Text] [Related]
5. BORIS, brother of the regulator of imprinted sites, is aberrantly expressed in hepatocellular carcinoma.
Chen K; Huang W; Huang B; Wei Y; Li B; Ge Y; Qin Y
Genet Test Mol Biomarkers; 2013 Feb; 17(2):160-5. PubMed ID: 23237599
[TBL] [Abstract][Full Text] [Related]
6. BORIS up-regulates OCT4 via histone methylation to promote cancer stem cell-like properties in human liver cancer cells.
Liu Q; Chen K; Liu Z; Huang Y; Zhao R; Wei L; Yu X; He J; Liu J; Qi J; Qin Y; Li B
Cancer Lett; 2017 Sep; 403():165-174. PubMed ID: 28645561
[TBL] [Abstract][Full Text] [Related]
7. Role of IQGAP3 in metastasis and epithelial-mesenchymal transition in human hepatocellular carcinoma.
Shi Y; Qin N; Zhou Q; Chen Y; Huang S; Chen B; Shen G; Jia H
J Transl Med; 2017 Aug; 15(1):176. PubMed ID: 28810875
[TBL] [Abstract][Full Text] [Related]
8. CASC15 promotes epithelial to mesenchymal transition and facilitates malignancy of hepatocellular carcinoma cells by increasing TWIST1 gene expression via miR-33a-5p sponging.
Li Y; Chen G; Yan Y; Fan Q
Eur J Pharmacol; 2019 Oct; 860():172589. PubMed ID: 31401158
[TBL] [Abstract][Full Text] [Related]
9. Humanized disulfide-stabilized diabody against fibroblast growth factor-2 inhibits PD-L1 expression and epithelial-mesenchymal transition in hepatoma cells through STAT3.
Sun H; Song X; Li C; Li Q; Liu S; Deng N
IUBMB Life; 2023 Nov; 75(11):957-968. PubMed ID: 37489553
[TBL] [Abstract][Full Text] [Related]
10. Promotion of hepatocellular carcinoma metastasis through matrix metalloproteinase activation by epithelial-mesenchymal transition regulator Twist1.
Zhao XL; Sun T; Che N; Sun D; Zhao N; Dong XY; Gu Q; Yao Z; Sun BC
J Cell Mol Med; 2011 Mar; 15(3):691-700. PubMed ID: 20219012
[TBL] [Abstract][Full Text] [Related]
11. Establishment and evaluation of cell and animal models expressing BORIS subfamily 2 variant.
Qin L; Liu ZJ; Xian LJ; Hu L; Fu Q; Chen LH; Qin Y
Ann Transl Med; 2022 Jun; 10(11):632. PubMed ID: 35813346
[TBL] [Abstract][Full Text] [Related]
12. Intratumoral hepatic stellate cells as a poor prognostic marker and a new treatment target for hepatocellular carcinoma.
Sun B; Zhang X; Cheng X; Zhang Y; Chen L; Shi L; Liu Z; Qian H; Wu M; Yin Z
PLoS One; 2013; 8(11):e80212. PubMed ID: 24278260
[TBL] [Abstract][Full Text] [Related]
13. Matrix stiffness modulates hepatic stellate cell activation into tumor-promoting myofibroblasts via E2F3-dependent signaling and regulates malignant progression.
Liu Z; Mo H; Liu R; Niu Y; Chen T; Xu Q; Tu K; Yang N
Cell Death Dis; 2021 Dec; 12(12):1134. PubMed ID: 34873170
[TBL] [Abstract][Full Text] [Related]
14. Periostin involved in the activated hepatic stellate cells-induced progression of residual hepatocellular carcinoma after sublethal heat treatment: its role and potential for therapeutic inhibition.
Zhang R; Lin XH; Ma M; Chen J; Chen J; Gao DM; Cui JF; Chen RX
J Transl Med; 2018 Nov; 16(1):302. PubMed ID: 30400797
[TBL] [Abstract][Full Text] [Related]
15. Hepatic stellate cell exosome-derived circWDR25 promotes the progression of hepatocellular carcinoma via the miRNA-4474-3P-ALOX-15 and EMT axes.
Liu L; Liao R; Wu Z; Du C; You Y; Que K; Duan Y; Yin K; Ye W
Biosci Trends; 2022 Sep; 16(4):267-281. PubMed ID: 35934785
[TBL] [Abstract][Full Text] [Related]
16. Runt-related transcription factor 3 reverses epithelial-mesenchymal transition in hepatocellular carcinoma.
Tanaka S; Shiraha H; Nakanishi Y; Nishina S; Matsubara M; Horiguchi S; Takaoka N; Iwamuro M; Kataoka J; Kuwaki K; Hagihara H; Toshimori J; Ohnishi H; Takaki A; Nakamura S; Nouso K; Yagi T; Yamamoto K
Int J Cancer; 2012 Dec; 131(11):2537-46. PubMed ID: 22488108
[TBL] [Abstract][Full Text] [Related]
17. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C
World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092
[TBL] [Abstract][Full Text] [Related]
18. STAT3 cooperates with Twist to mediate epithelial-mesenchymal transition in human hepatocellular carcinoma cells.
Zhang C; Guo F; Xu G; Ma J; Shao F
Oncol Rep; 2015 Apr; 33(4):1872-82. PubMed ID: 25653024
[TBL] [Abstract][Full Text] [Related]
19. Lipocalin-2 negatively modulates the epithelial-to-mesenchymal transition in hepatocellular carcinoma through the epidermal growth factor (TGF-beta1)/Lcn2/Twist1 pathway.
Wang YP; Yu GR; Lee MJ; Lee SY; Chu IS; Leem SH; Kim DG
Hepatology; 2013 Oct; 58(4):1349-61. PubMed ID: 23696034
[TBL] [Abstract][Full Text] [Related]
20. HCRP1 downregulation promotes hepatocellular carcinoma cell migration and invasion through the induction of EGFR activation and epithelial-mesenchymal transition.
Xu J; Zhang X; Wang H; Ge S; Gao T; Song L; Wang X; Li H; Qin Y; Zhang Z
Biomed Pharmacother; 2017 Apr; 88():421-429. PubMed ID: 28122307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
